EB105/28
1. S.M. $OL I.
1
³ ,,,
´
(%1*2 2. (%1*2 ª (%1*2 / 2
©
1
S.M. Ali ); J.-L. Mamdaba ( C. Komodikis la Jara 2
F. Savvides)
; J. Jimenez de G.M. van Etten .
EB105/28
3. ª ©
II. (%1*2:3 4. 5.
(% 1.
(%1*2:3
6.
1
EB103/1999/REC/1,
2
EB105/28
7.
±
8.
9. (%1*2:3
3
EB105/28
10.
11. 12. 2
1
(%1*2:3
1 2
EB97(15). EB99(17).
4
EB105/28
13.
14.
15.
5
EB105/28
16. 1*2:3 17. Collegium Internationale 1HXUR3V\FKRSKDUPDFRORJLXP 19. 20. 1HXUR3V\FKRSKDUPDFRORJLXP Collegium Internationale
18.
1*2:3
6
EB105/28
&ROOHJLXP 21. Internationale 1HXUR3V\FKRSKDUPDFRORJLXP
Collegium
III.
1 1. © ª
2.
1
7
EB105/28
©
ª
Collegium Internationale Neuro-Psychopharmacologicum Collegium.
8
EB105/28
Christoffel-Blindenmission* Collegium Internationale Neuro-Psychopharmacologicum )',
* *
9
EB105/28
25%,6 ,QWHUQDWLRQDO Inc.* © World heart*
ª
=
=
=
10